Close
  Indian J Med Microbiol
 

Figure 1: (A) Percentage of CD34+CD45lo haematopoietic stem and progenitor cells in PBSC harvests from cancer patients and healthy donors. The dot plot depicts percentage of CD34+CD45lo haematopoietic stem and progenitor cells in PBSC harvests of cancer patients (n=46; left side) and healthy donors (n=28; right side). Horizontal/vertical bars on each dot plot indicate mean±standard error. (B) Percentage of CD34+CD45lo haematopoietic stem and progenitor cells in PBSC harvests from cancer patients and healthy donors. Increase in per cent CD34+CD45lo haematopoietic stem and progenitor cells within pre- and post-enriched PBSC harvests (autograft and allograft; n=35). HSPC: Haematopoietic stem and progenitor cells; PBSC: Peripheral blood stem cell.

Figure 1: (<b>A</b>) Percentage of CD34+CD45<sup>lo</sup> haematopoietic stem and progenitor cells in PBSC harvests from cancer patients and healthy donors. The dot plot depicts percentage of CD34+CD45<sup>lo</sup> haematopoietic stem and progenitor cells in PBSC harvests of cancer patients (n=46; left side) and healthy donors (n=28; right side). Horizontal/vertical bars on each dot plot indicate mean±standard error. (<b>B</b>) Percentage of CD34+CD45<sup>lo</sup> haematopoietic stem and progenitor cells in PBSC harvests from cancer patients and healthy donors. Increase in per cent CD34+CD45<sup>lo</sup> haematopoietic stem and progenitor cells within pre- and post-enriched PBSC harvests (autograft and allograft; n=35). HSPC: Haematopoietic stem and progenitor cells; PBSC: Peripheral blood stem cell.